AAAAAA
Results:
1-7
|
Results: 7
Authors:
Hofferbert, S
Worringen, U
Backe, J
Ruckert, EM
White, K
Faller, H
Grimm, T
Caffier, H
Chang-Claude, J
Weber, BHF
Citation: S. Hofferbert et al., Simultaneous interdisciplinary counseling in German breast/ovarian cancer families: First experiences with patient perceptions, surveillance behaviorand acceptance of genetic testing, GEN COUNSEL, 11(2), 2000, pp. 127-146
Authors:
Sutterlin, MW
Haller, A
Gassel, AM
Peters, K
Caffier, H
Dietl, J
Citation: Mw. Sutterlin et al., The correlation of c-erbB-2 oncoprotein and established prognostic factorsin human breast cancer, ANTICANC R, 20(6D), 2000, pp. 5083-5088
Authors:
Oehler, MK
Caffier, H
Citation: Mk. Oehler et H. Caffier, Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer, ANTICANC R, 20(6D), 2000, pp. 5109-5112
Authors:
Oehler, MK
Sutterlin, M
Caffier, H
Citation: Mk. Oehler et al., CASA and CA 125 in diagnosis and follow-up of advanced ovarian cancer, ANTICANC R, 19(4A), 1999, pp. 2513-2518
Authors:
Oehler, MK
Caffier, H
Citation: Mk. Oehler et H. Caffier, Diagnostic value of serum VEGF in women with ovarian tumors, ANTICANC R, 19(4A), 1999, pp. 2519-2522
Authors:
Heimburg, S
Oehler, MK
Papadopoulos, T
Caffier, H
Kristen, P
Dietl, J
Citation: S. Heimburg et al., Prognostic relevance of the endothelial marker CD 34 in ovarian cancer, ANTICANC R, 19(4A), 1999, pp. 2527-2529
Authors:
Sutterlin, M
Bussen, S
Trott, S
Caffier, H
Citation: M. Sutterlin et al., Predictive value of CEA and CA 15-3 in the follow up of invasive breast cancer, ANTICANC R, 19(4A), 1999, pp. 2567-2570
Risultati:
1-7
|